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Abstract
Background: Intra-operative radiation therapy (IORT) is the transfer of a single large radiation
dose to the tumor bed during surgery with the final goal of improving regional tumor control. This
study aimed to investigate the safety, effectiveness and economic evaluation of intra-operative radia-
tion therapy.
Methods: The scientific literature was searched in the main biomedical databases (Centre for Re-
views and Dissemination, Cochrane Library and PubMed) up to March 2014. Two independent re-
viewers selected the papers based on pre-established inclusion criteria, with any disagreements being
resolved by consensus. Data were then extracted and summarized in a structured form. Results from
studies were analyzed and discussed within a descriptive synthesis.
Results: Sixteen studies met the inclusion criteria. It seems that outcomes from using intra-
operative radiation therapy can be considered in various kinds of cancers like breast, pancreatic and
colorectal cancers. The application of this method may provide significant survival increase only for
colorectal cancer, but this increase was not significant for other types of cancer. This technology had
low complications; and it is relatively safe. Using intra-operative radiation therapy could potentially
be accounted as a cost-effective strategy for controlling and managing breast cancer.
Conclusion: According to the existing evidences, that are the highest medical evidences for using
intra-operative radiation therapy, one can generally conclude that intra-operative radiation therapy is
considered as a relatively safe and cost-effective method for managing early-stage breast cancer and
it can significantly increase the survival of patients with colorectal cancer. Also, the results of this
study have policy implications with respect to the reimbursement of this technology.
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Introduction
Cancer is commonly used for great group
of diseases that can influence any part of
the body. One of the specifications defining
cancer includes fast reproduction of ab-
normal cells beyond their regular duplica-
tion that can attack their neighborhood
sides and diffuse to other organs of the
body. This is called metastasis. Metastasis
is the main cause of death from cancer.
Cancer is the main reason for mortality
worldwide, there were over than 8.3 million
mortalities in 2012. Main types of cancer
include: lung cancer (1.59 million deaths
per year), liver cancer (74500 deaths per
year), stomach (72300 deaths per year), co-
lon (694000 deaths per year), breast cancer
(521000 deaths per year) and esophageal
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cancer (400,000 deaths per year). Some of
the most prevalent kinds of cancer such as
breast, cervix, mouth and colon cancers,
when diagnosed early and treated by best
methods could have high therapeutic suc-
cess. Some types of cancers including leu-
kemia and lymphoma in children can have
high improvement rate even after diffusion
with proper treatments. Cancer treatment
needs accurate selections of one or more of
some interventions such as surgery, radia-
tion therapy and chemotherapy. It comes
with this goal that while improving the
quality of life in the patient, it can also in-
crease their life years through treating the
disease (1).
Radiation therapy as an important part of
combination therapy of cancer has been
considerably attended during recent dec-
ades; its philosophy includes attaining to
higher and more effective dosages of radia-
tion without increasing the prevalence of its
complication (2). For improving the clinical
consequences of cancer, various radio-
therapeutic methods are used including Ex-
ternal Beam Radiation Therapy (EBRT),
Intensity-Modulated Radiation Therapy
(IMRT), 3-Dimensional Conformal Radia-
tion Therapy (3D-CRT) and Intraoperative
radiation therapy (IORT) (3). One of these
techniques which were mentioned above,
called IORT, is a technique to deliver a
high dose of radiation to a locally advanced
tumor to protect the neighboring normal
tissues at the time of surgery (3). During
IORT, the normal tissues are not exposed to
radiation because they are removed or
shielded from the treatment field (4,5).
Therefore, by the advent of the technology
in Iran and considering the fact that recent-
ly there has been a high demand for reim-
bursing such a technology by insurance
companies, this study aimed to review the
safety, effectiveness and economic evalua-
tion of IORT for the treatment of patients
with different cancer types.
Methods
Scientific literature was searched in the
main biomedical databases up to March
2014: Centre for Reviews and Dissemina-
tion (Health Technology Assessment, Da-
tabase of Abstracts of Reviews of Effec-
tiveness, and NHS Economic Evaluation
Database), Cochrane Library and PubMed.
Mesh and free text were used in the search
strategy (Table 1). Duplicated and non-
relevant studies were removed. The titles
and abstracts of the remaining studies were
investigated and unrelated studies were ex-
cluded. The full texts of the remaining arti-
cles were checked against the inclusion cri-
teria to select studies for the review (Fig.
1). Two independent reviewers checked the
selected studies in accordance with inclu-
sion criteria, with any disagreements being
resolved by consensus. A structured form
was used to collect data from the included
studies. The criteria were as follows: (1)
The study design, systematic reviews, me-
ta-analysis, health technology assessment
and economic evaluations; (2) Treatment
type: patients who received intraoperative
radiotherapy (IORT) or other prevalent
methods used for radiotherapy; (3) Patient
type: patient diagnosed with cancer in any
stage; (4) Language: only publications in
English or English abstracts were included;
(5) Outcome: Overall survival, complica-
tions, expected life years, doses of irradia-
tion, costs and surgical time were consid-
ered as outcome. Because this was a rapid
review study, the quality of papers investi-
gated in this study was not critically as-
sessed; however, because the studied pa-
pers have been provided from Cochrane
library and Centre for Reviews and Dis-
semination (CRD), it could be stated that
these databases can provide highest level of
quality for medical papers based on evi-
Table 1. Search Strategy
No. Search strategy
#1) “Intraoperative Radiation Therapy”
#2) “IORT”
#3) (#1 or #2)
#4) “Health Technology Assessment”
#5) “Systematic Review”
#6) “Cost*”
#7) (#3 and #4)
#8) (#3 and #5)
#9) (#3 and #6)
#10) (#7 or #8 or #9)
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dences. Finally, qualitative analysis was
done using thematic synthesis.
In this study, the search strategy was as
Table 1.
Results
Sixteen studies met the inclusion criteria
and comprised 9 systematic reviews (2, 3,
6-12), one health technology assessment
(13), one literature review (14), four eco-
nomic evaluation (15-18) and one health
technology horizon scanning (19). Two
studies were published in 2014 (16, 18),
three in 2013 (2, 10, 15), three in 2012 (3,
6, 13), two in 2011 (8, 12), one in 2010
(17), one in 2009 (7), one in 2008 (11) and
three in 2004 (9, 14, 19) (Table 2). Results
were presented in six sub-categories includ-
ing survival rate, complications, life ex-
pected years, irradiation rate, costs and sur-
gical times.  Also, included studies on the
basis of cancer types were as follows: ten
on breast cancer (2,6,7,9,12,13,15,16,18,
19), three on colorectal cancer (7,8,10), one
on pancreatic cancer (11), one on pelvic
gynecologic malignancies (14), one on
prostate cancer (3), one on liver cancer
(17). Table 2 reflects the main characteris-
tics of the studies.
A-Safety
A-1- Complications
In the study conducted by Cucins- Hearn
et al. on using IORT in breast cancer, less
complications after operation was reported;
therefore, one cannot determine the relative
Fig. 1. Flow of papers through the study
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safety and effectiveness of using IORT
compared to BCT (9). Ruano- Ravina et al.
concluded that there were less occurrence
of chronic and acute complications when
using combined therapy with IORT and
EBRT for breast cancer in early stages (12).
In a study, Cantero- Munoz et al. indicated
that using IORT in treating breast cancer is
a relatively safe method because its ob-
served complication is similar to that of
external radiotherapy (7). In another study,
Cantero- Munoz et al. concluded that acute
complications from the use of IORT in col-
orectal cancer was mainly of gastro-
intestinal type, and IORT technology is a
safe method with no increase in the toxicity
resulted from conventional treatment (8). In
another study by Cantero- Munoz et al. it
was found that using IORT individually for
breast cancer may not considerably im-
prove the toxicity of conventional treatment
(2). Mirnezami et al. did not report any in-
crease in general side effects whether uro-
logic or anastomotic when using IORT in
colorectal cancer. Also, their results re-
vealed that IORT may improve the onco-
Table 2. List of included papers
Author, Location,
Publication Date
Paper Title Comparing
Methods
Study Type
Alvarado et al. (15)
USA, 2013
Cost-Effectiveness Analysis of Intraoperative Radiation
Therapy for Early-Stage Breast Cancer
WB-EBRT Economic
Evaluation
Bahadur et al. (6)
Saudi Arabia, 2012
Tumor bed boost radiotherapy in breast cancer: A re-
view of current techniques
EBRT, HDR,
IMRT
Systematic
Review
Cantero Muñoz et
al. (7)
Spain, 2009
Radioterapia intraoperatoria en cáncer de mama y
cáncer colorectal/ Intraoperative radiotherapy in breast
and colorectal cancer
External Radiother-
apy
Systematic
Review
Cantero-Muñoz et
al. (2)
Spain, 2013
Radioterapia intraoperatoria en el tratamiento del can-
cer de mama/ Intraoperative radiation therapy in the
treatment of breast cancer
External Radiation Systematic
Review
Cantero-Muñoz et
al. (8)
Spain, 2011
Efficacy and safety of intraoperative radiotherapy in
colorectal cancer: A systematic review
Conventional
Treatment
Systematic
Review
Commonwealth Of
Australia (19)
Australia, 2004
Intraoperative Radiation Therapy BCT Horizon
Scanning
Cuncins-Hearn et
al. (9)
Australia, 2004
A systematic review of intraoperative radiotherapy in
early breast cancer
BCT Systematic
Review
Esserman et al. (16)
USA, 2014
Application of a decision analytic framework for adop-
tion of clinical trial results: are the data regarding
TARGIT-A IORT ready for prime time?
EBRT Economic
Evaluation
Glujovsky (14)
Argentina, 2004
Radioterapia intraoperatoria (IORT) en cánceres
ginecológicos pelvianos/ Intraoperative radiation thera-
py in pelvic gynecologic malignancies
Conventional
Treatment
Literature
Review
LU et al. (17)
China, 2010
Study of intra-operative radiotherapy in primary liver
cancer
3D-CRT Economic
Evaluation
Marchioro et al. (3)
Italy, 2012
Radical Prostatectomy and Intraoperative Radiation
Therapy in High-Risk Prostate Cancer
Conventional
EBRT
Systematic
Review
Mirnezami et al.
(10)
UK, 2013
Intraoperative radiotherapy in colorectal cancer: Sys-
tematic review and meta-analysis of techniques, long-
term outcomes, and complications
no IORT Systematic
Review, meta-
analysis
Ruano-Ravina et al.
(11)
Spain, 2008
Intraoperative radiotherapy in pancreatic cancer: A
systematic review
External radiother-
apy
Systematic
Review
Ruano-Ravina et al.
(12)
Spain, 2011
Efficacy and safety of intraoperative radiotherapy in
breast cancer: A systematic review
EBRT Systematic
Review
Shah et al. (18)
USA, 2014
Evaluating Radiotherapy Options in Breast Cancer:
Does Intraoperative Radiotherapy Represent the Most
Cost-Efficacious Option?
APBI and WBI Economic
Evaluation
Xie et al. (13)
Canada, 2012
Single-dose Intraoperative Radiotherapy Using Intra-
beam® for Early-stage Breast cancer: A Health Tech-
nology Assessment
Conventional Ex-
ternal Beam Irradia-
tion
Health
Technology
Assessment
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logical outcomes in advanced and recur-
rence colorectal cancer (10). Xie et al. con-
cluded that in breast cancer, the rate of
main complications for using IORT is simi-
lar to conventional treatment by external
radiotherapy (13). Marchioro et al. indicat-
ed that Intraoperative Electron Radiation
Therapy (IOERT) is a preferred method
with minimum toxicity (3).
B- Effectiveness
B-1- Survival Rate
Cuncins- Hearn et al. showed that short-
term outcomes for both treatment methods,
IORT and Breast Conserving Therapy
(BCT), in the early-stage breast cancer
were similar in term of local recurrence,
disease-free survival and overall survival.
However, the existing evidence base for
using IORT in early breast cancer is poor
(9). Ruano-Ravina et al. found that IORT
may cause a slight increase survival among
patients with pancreatic cancer in localized
stages. However, the results were not in
favor of IORT in the case of pancreatic
cancer in the locally advanced and meta-
static stages (11). Bahadur et al. concluded
that the difference in the overall survival,
disease-free survival and disease-free dis-
tant survival among 4 interventions includ-
ing External Beam Radiation Therapy
(EBRT), High Dose Rate (HDR), Intensity-
Modulated Radiation Therapy (IMRT) and
IORT in breast cancer is not significant (6).
Ruano- Ravina et al. found that in com-
bined therapy with IORT and EBRT in ear-
ly-stage breast cancer, local control was
over 95% for 1 and 4 years of follow-up,
and the 5-year overall survival was 99%.
TARGIT-A(TARGeted Intraoperative radi-
oTherapy Alone) study found a similar sur-
vival for IORT compared to standard
treatment (12). Cantero- Munoz et al. indi-
cated that using IORT in breast cancer
causes slight improvement in their survival
rate than patients treated by other treat-
ments (7).  Cantero- Munoz et al. in another
study concluded that the use of IORT for
colorectal cancer, five-to-six-year local
control was over 80% and 5-year overall
survival was close to 65%. For recurrences,
the 5- year overall survival was 30%. Also,
their study showed that adding IORT to
conventional treatment reduces the inci-
dence of local recurrences within the radia-
tion area over 10%(8). In another study
conducted to assess the effectiveness of
IORT as a replacement treatment for cur-
rent standard treatment of breast cancer,
Cantero- Munoz et al. found that results
from studies assessing the IORT as a re-
placement for a dosage promoting the ex-
ternal radiation indicate that this combina-
tion may not increase the effectiveness and
overall survival. Using IORT individually
may have recurrence and metastasis similar
to conventional treatment (2). Mirnezami et
al. concluded that using IORT in colorectal
cancer may have a significant effect on im-
proving the localized control, overall sur-
vival and disease-free survival (10). Aus-
tralian Horizon scanning Report declared
that according to the existing evidences, the
safety and relative effectiveness of IORT to
maintain the breast with post-operative ra-
diation therapy has not been yet clear com-
pared to surgery (19). Glujovsky et al. indi-
cated that intra-operative radiation therapy
in the gynecology cancers should be only
considered in terms of clinical protocols
and tests. Extended usage of this method
may not be recommended in daily clinical
practice. It seems that IORT may be poten-
tially effective for patients with localized
recurrence in their pelvic wall (14). Xie et
al. concluded that in breast cancer, the lo-
calized recurrence rate for inter-operative
radiation therapy is similar to traditional
treatments with external radiation therapy
(13).
B-2- Life Expected Years
Esserman et al. found that in breast can-
cer, by using IORT during primary stages
and with increase in the rate of localized
recurrence of IORT more than 10% during
10 years, only less than 0.002 life expec-
tancy (less than one day) can be expected
compared to EBRT (16). Alvarado et al. in
their study indicated that in early stages of
Safety, effectiveness and economic evaluation of intra-operative radiation…
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Table 3. Effectiveness outcomes and cost aspects in the studies
Comparator Type of cancer Overall Survival Complications Expected Life Years Doses of Irradiation Costs Surgical Time
Alvarado et al. (15)
USA, 2013
WB-EBRT Breast Cancer Slightly higher in local recur-
rence rate.
- Slightly less effec-
tive (a difference of
0.062 days)
- Dominant (less
costly and more
QALYs)
-
Bahadur et al. (6)
Saudi Arabia, 2012
EBRT, HDR,
IMRT
Breast Cancer no significant difference
regarding the overall survival,
disease free survival, and
distant disease free survival
- - - - -
Cantero Muñoz et al. (7)
Spain, 2009
External Radio-
therapy
Breast and
Colorectal
Cancer
Slightly better survival rate Relatively safe tech-
nique.
Adverse effects is
similar.
- - - -
Cantero-Muñoz et al. (2)
Spain, 2013
External Radia-
tion
Breast Cancer incidence of recurrences and
metastasis is similar
similar toxicity - - - -
Cantero-Muñoz et al. (8)
Spain, 2011
Conventional
Treatment
Colorectal
Cancer
5-6-year local control: 80%.
5-year overall survival: 65%.
For recurrences, the 5- year
overall survival: 30%.
IORT to reduce the incidence
of local recurrences within
the radiation area over 10%.
The main acute com-
plications were gastro-
intestinal
- - - -
Commonwealth Of Aus-
tralia (19)
Australia, 2004
BCT Breast Cancer - Minor complications
in the short-term and
the cosmetic outcome
were similar.
The relative safety and
efficacy is still uncer-
tain.
- Has potential to
minimize irradiation
of normal tissue
- Has potential
to shorten the
course of
radiotherapy
treatment
Cuncins-Hearn et al. (9)
Australia, 2004
BCT Breast Cancer similar Short-term outcome
in terms of local recurrence,
disease-free and overall sur-
vival
Minor postoperative
complications
- - - -
Esserman et al. (16)
USA, 2014
EBRT Breast Cancer - similar frequency of
major toxicities
At an local recur-
rence rate of 10%,
only 0.002 fewer
expected life years
- $1.7 billion oppor-
tunity cost of wait-
ing an additional
five year.
Offer similar life
expectancy, but
cost less.
Reduce $1467 in
-
F. Najafipour, et al.
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indirect costs per
patient.
Glujovsky (14)
Argentina, 2004
Conventional
Treatment
Pelvic Gyneco-
logic Malig-
nancies
Has higher benefit for pa-
tients with local recurrence
involving the pelvic wall.
- - - - -
LU et al. (17)
China, 2010
3D-CRT Primary Liver
Cancer
- - - Effectively protect
the neighboring
sensitive organs and
improve the ab-
sorbed dose in the
tumors and the local
control rate.
The cost was signif-
icantly lower
-
Marchioro et al. (3)
Italy, 2012
conventional
EBRT
Prostate Cancer - Minimal toxicity - - - Acceptable
Mirnezami et al. (10)
UK, 2013
no IORT Colorectal
Cancer
A significant effect favoring
improved local control ,dis-
ease free survival and overall
survival.
No increase in total,
urologic or anastomot-
ic complications.
Increased wound
complications.
- - - -
Ruano-Ravina et al. (11)
Spain, 2008
External radio-
therapy
Pancreatic
Cancer
Slightly increase survival
among patients with pancreat-
ic cancer in localized stages.
- - - - -
Ruano-Ravina et al. (12)
Spain, 2011
EBRT Breast Cancer Local control was over 95%
for 1 and 4 years of follow-
up and the 5-year overall
survival was 99%. The simi-
lar survival comparing IORT
with standard treatment.
no differences in survival for
IORT treated patients versus
standard treatment
The incidence of
acute and chronic
complications was
scarce.
Acute and late toxici-
ties are low.
- - - -
Shah et al. (18)
USA, 2014
APBI and WBI Breast Cancer - - - - More costs per
QALY
-
Xie et al. (13)
Canada, 2012
Conventional
External Beam
Irradiation
Breast Cancer the rates of local recurrence is
similar
the rates of major
complications is simi-
lar
- - For 100 patients per
year the budget
impact of IORT
would be a saving
of $146,300.
-
Safety, effectiveness and economic evaluation of intra-operative radiation…
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breast cancer, single dosage IORT has
lower effectiveness than 6 weeks Whole-
Breast External Beam Radiation Therapy
(WB-EBRT) (15).
B-3- Radiation Rate
Xie et al. concluded that using IORT in
breast cancer may reduce the workload of
oncological radiation team. In the patients’
point of view, using IORT may considera-
bly reduce the troubling weekly external
radiation as well as waiting time for radia-
tion therapy patients (13). Lu indicated that
using IORT in primary liver cancer may
effectively protect from adjacent sensitive
tissues with improving the dosage absorbed
in the tumors as well as local control rate
(17).
C-Economic Evaluation
C-1- Cost of Treatment
Xie et al. concluded that using single dos-
age IORT in breast cancer may slightly re-
duce or increase in the budget expenditures
based on the patients’ turnover (13). Es-
serman et al. found that there will be an op-
portunity cost amounted to 1.7 billion USD
for using IORT during a 5 year period for
low risk females, hormone receptor- posi-
tive and postmenopausal females (16). Al-
varado et al. indicated that single dosage
IORT during operation in early stage breast
cancer is considered as a dominated treat-
ment with a more cost effective strategy by
providing more life expectancy based on
quality of living together with reduced
costs compared to 6 weeks of administrat-
ing the WB-EBRT. Compared to WB-
EBRT, IORT has lower cost and higher
QALY with valuable strategy. IORT is an
example of new technology with cost lower
than existing treatment standard but with
similar clinical effectiveness (15). Lu con-
cluded that cost of using IORT in primary
liver cancer is considerably lower than 3-
Dimentional Conformal Radiation Therapy
(3D-CRT) (17). Shah et al. in their study
indicated that for treating 1000 patients af-
fected by breast cancer, the cost savings for
using IORT compared to WB-3D-CRT,
APBI-IMRT, APBI-SL, APBI-ML and
APBI-I is 3.6-4.3 million dollars, 1.6-2.4
million dollars, 3.6 to 4.4 million dollars,
7.5 – 8.2 million dollars and 2.8 to 3.6 mil-
lion dollars, respectively and compared to
APBI 3D-CRT, it saves costs up to 1.6 to
2.4 million dollars. The cost per QALY for
WBI-3D CRT, APBI-IMRT, APBI-SL,
APBI-ML and APBI-I compared to IORT
was 47990 to 60002 dollars, 17335 to
29347 dollars, 49019 to 61031 dollars,
108162 to 120173 dollars and 36129 to
48141 dollars, respectively. According to
the results of this study, APBI and WBI
were cost-effective compared to IORT.
They concluded that according to the anal-
ysis of costs minimization, IORT has the
potential for cost savings in managing ear-
ly-stage breast cancer; however, consider-
ing the additional medical and non- medical
costs, WBI and APBI are cost-effective
modalities based cost-per-QALY  analyses
and will be yet remained as standard  of
treatment (18).
C-2- Surgery Time
Xie et al. concluded that using IORT
technology may result in increase of opera-
tion room load with increase in waiting
time for surgery (13). Marchioro et al. indi-
cated that IOERT is considered as a method
with acceptable surgery time (3).
Discussion
According to the studies, it seems that in
this case, using this method for colorectal
cancer could only significantly increase the
survival rate with no significant effect on
other types of cancer (6-8,10-12,15). Be-
cause of the complications of using this
kind of radiation therapy, the studies gener-
ally focused on post-operative complica-
tions and toxicity from using intra-
operative radiation therapy, and it seems
that such complications are slight and this
technology can be safely used in all types
of cancer (2, 6-10, 12, 13, 16, 19). For life
expectancy, in breast cancer, if IORT local-
ized recurrence rate was high about 10%
per 10 years and IORT is applied in early
F. Najafipour, et al.
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stage of disease, we will expect 0.002 few-
er life years (less than one day) compared
to EBRT. Also, in primary stages of breast
cancer, single dosage IORT is less effective
compared to 6-week WB-EBRT, with the
rate of 0.062 days (15, 16). By IORT, one
can attack the site of neoplasm with higher
accuracy without damaging the intact tis-
sues by radiation (17,19). Studies indicate
that using intra-operative radiation therapy
may be potentially accounted as a cost-
effective strategy for controlling and man-
aging breast cancer (15-17). Using IOERT
may be conducted during an acceptable
surgical time. However, this aspect has het-
erogeneity because it has also been pointed
that using IORT technology may increase
the load of operation room by increasing
the waiting time for surgery operation (3,
13). Based on the current level of evidence,
that are the highest level of evidence on the
Evidence Base Medicine pyramid for using
intra-operative radiation therapy, it can be
generally concluded that IORT is a relative-
ly safe and cost-effective treatment method
for managing the early-stage breast cancer
and it can also significantly increase the
survival of colorectal cancer patients. In
addition, the results of this study have im-
plications with respect to reimbursement of
this technology. Given that the results of
economic evaluation studies in other coun-
tries cannot be generalized to other con-
texts, an economic evaluation study on
IORT needs to be undertaken in our coun-
try.
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